Exec Director, Regulatory RWE Strategy and Innovation

At Gilead were creating a healthier world for all people. For more than 35 years weve tackled diseases such as HIV viral hepatitis COVID-19 and cancer working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the worlds biggest health challenges and our mission requires collaboration determination and a relentless drive to make a difference.

Every member of Gileads team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions and were looking for the next wave of passionate and ambitious people ready to make a direct impact.

We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future you are the key driver in evolving our culture and creating an environment where every employee feels included developed and empowered to fulfil their aspirations. Join Gilead and help create possible together.

Job Description

The Epidemiology & Real-World Evidence (EpiRWE) function at Gilead is part of the Clinical Data Sciences (CDS) group within the Clinical Development organization and aims to unlock the power of Real-World Evidence (RWE) to help transform innovations to life-changing medicines for patients.

RWE is increasingly informing regulatory decisions across development and the product lifecycle. At the same time evolving health authority expectations modern study designs advanced analytics and a rapidly expanding external RWE ecosystem create both opportunity and complexity for development teams.

Reporting to the Vice President of Epidemiology and Real-World Evidence (EpiRWE) the Executive Director Regulatory RWE Strategy and Innovation is a scientific and strategic leader who enables Gilead to move from ad hoc program-specific use of regulatory-facing RWE to a more systematic and forward-looking enterprise-level approach. To advance appropriate use of RWE for regulatory decision-making this role will provide the cross-portfolio perspective and senior expertise to interpret the shifts in the regulatory and industry landscape identify and prioritize high-impact applications of RWE and translate emerging policy and precedent into coherent enterprise strategy across therapeutic areas programs and lifecycle stages. The role works through partnership with therapeutic-area EpiRWE Heads and their teams Global Regulatory Affairs Biostatistics Clinical Development Clinical Pharmacology Patient Safety Medical Affairs and other stakeholders. These functions retain ownership of their respective programs studies submissions and relationships with stakeholders and health authorities; this role adds coordinated enterprise strategy specialized expertise and consistent standards so that Gilead can anticipate change apply emerging approaches deliberately and lead rather than react.

The successful candidate will connect and help shape policy methodology external innovation and practical execution while helping build the infrastructure required to use RWE credibly and compliantly for regulatory purposes. They will establish and steward fit-for-purpose decision frameworks templates documentation expectations quality controls and knowledge-sharing mechanisms that promote transparency reproducibility audit readiness and consistent execution across the doing so the leader will help teams determine when RWE is fit for purpose strengthen regulator-facing evidence plans reduce duplication and variability develop policy-shaping opportunities and identify credible external partners that can extend Gileads capabilities and impact. This durable enterprise capability will position Gilead to respond efficiently as evidentiary standards mature and to generate regulatory-grade RWE with the scientific rigor quality and compliance expected by global health authorities.

Partner with therapeutic area EpiRWE Heads Clinical Development and Global Regulatory Affairs to identify and prioritize opportunities where RWE may accelerate development strengthen evidence packages support label expansion address post-marketing requirements or commitments or improve the efficiency of evidence generation.

Provide senior scientific consultation on fit-for-purpose data study design endpoint and covariate ascertainment validation feasibility and documentation for regulator-facing evidence.

Facilitate early cross-functional review of proposed regulatory-facing RWE approaches and provide clear decision-ready recommendations while preserving program and functional ownership.

Translate enterprise learning and external precedents into practical decision frameworks that teams can apply across therapeutic areas and lifecycle stages.

Partner with Global Regulatory Affairs who are responsible for agency strategy and relationships and with program and therapeutic-area teams to shape enterprise strategy for regulatory filing and engagement as well as develop RWE and methodological content for briefing packages meeting requests submissions and responses to health authority questions.

Support preparation for and when appropriate participate in FDA Type B/C meetings EMA scientific advice and other global health authority interactions in which RWE external controls hybrid designs or novel endpoints are material.

Help coordinate cross-program and cross-region RWE engagement priorities so that scientific positions are consistent precedents are shared and agency feedback is translated into action.

In partnership with therapeutic area EpiRWE teams Biostatistics and Clinical Development teams advance fit-for-purpose RWE to support regulatory engagement including external and hybrid controls target trial emulation causal inference natural history studies phase 0/lead-in studies pragmatic and registry-based designs and other innovative approaches.

Provide regulatory-science perspective on novel analytical methods including Bayesian borrowing complex innovative designs estimands and the documented use of AI/ML or natural language processing in data curation phenotyping and endpoint derivation.

Partner with clinical patient-centered outcomes and other endpoint experts on the selection validation and regulatory positioning of clinical outcome assessments digital measures and other novel endpoints.

Monitor and translate global RWE policy and evidentiary developments into implications for Gilead programs portfolio strategy and enterprise capabilities.

Develop and advance policy-shaping priorities related to the regulatory use of RWE including concepts that could inform future PDUFA demonstration projects pilots commitments or other public-private initiatives.

Coordinate Gilead technical input to draft guidance and consultations and represent Gilead in relevant consortia trade associations professional societies and multi-stakeholder initiatives in alignment with accountable internal functions.

Identify focused partnerships with academia professional societies trade groups patient advocacy organizations and other stakeholders that can address gaps test methods build consensus or advance standards for regulatory-grade RWE.

Maintain a strategic view of the evolving external environment pertaining to RWE for regulatory use including data providers CROs technology companies methodological experts academic centers and specialized service organizations.

Partner with Sourcing Legal Privacy Quality and functional experts to establish fit-for-purpose evaluation criteria and support due diligence of prospective partners including scientific credibility data provenance and quality regulatory experience transparency reproducibility audit readiness scalability and potential conflicts of interest.

Help functions identify credible partners for specific needs avoid duplicative or low-value engagements and capture performance and lessons learned to inform future partner selection and investment.

Provide scientific input to strategic vendor relationships requests-for-proposal capability assessments and external investment decisions without displacing accountable business owners.

Co-develop and steward practical standards templates governance and quality expectations for regulatory-facing RWE aligned with applicable regulations guidance Good Pharmacoepidemiology Practices and internal procedures.

Create forums training and mentoring programs to strengthen regulatory and methodological judgment across RWE and partner functions and enable teams to apply consistent approaches.

Deliver concise executive-level briefings on policy shifts external developments precedents risks and portfolio opportunities.

Contribute as a member of the EpiRWE leadership team to functional vision prioritization ways of working and enterprise initiatives employee development and inform resource and investment decisions for enterprise capability data assets and external partnerships

PhD MD PharmD DrPH or ScD in epidemiology biostatistics pharmacoepidemiology public health or a related quantitative or clinical science with 12 years of relevant experience; OR MS/MPH in a relevant discipline with 14 years of relevant experience.

Demonstrated leadership of observational research or RWE intended to support regulatory decision-making including experience in at least one program in which RWE materially contributed to a submission approval label expansion or post-marketing requirement or commitment.

Direct experience developing regulator-facing evidence content and participating in health authority interactions including briefing documents and written responses.

Demonstrated understanding of late-stage clinical development and registrational evidence requirements including applicable data standards documentation quality and inspection considerations relevant to observational and hybrid approaches.

Expert knowledge of the global RWE regulatory landscape and strong command of real-world data sources fit-for-purpose assessment feasibility validation and advanced observational or hybrid study designs.

Ability to translate complex methodological and policy issues into clear recommendations for program teams governance bodies and senior R&D leaders.

Proven ability to influence across a global matrix build trusted partnerships and establish standards or capabilities adopted beyond ones immediate team.

Experience evaluating or managing external data research or service partners including vendors CROs academic collaborators or consortia.

Experience working at a health authority/regulatory agency or comparable direct exposure to regulatory review and adjudication of evidence packages.

People leadership experience combined with effectiveness as an enterprise individual contributor and matrix leader.

Experience with innovative methods such as Bayesian methods external or historical data borrowing complex innovative designs estimand strategy clinical outcome assessments or digital and novel endpoints in a regulatory context.

Contributions to health authority policy guidance PDUFA-related initiatives industry consortia trade associations professional societies or multi-stakeholder collaborations.

Breadth across therapeutic areas modalities or both more prevalent and rare disease development programs.

Strong publication and presentation record in pharmacoepidemiology regulatory science interventional studies or related fields; experience with AI/ML or natural language processing applied to real-world data in regulatory context is a plus.

Location: Foster City CA. Onsite.

Travel: Approximately 10-15% domestic and international including health authority meetings partner engagements and scientific congresses.

The salary range for this position is: $324615.00 - $420090.00. Gilead considers a variety of factors when determining base compensation including experience qualifications and geographic location. These considerations mean actual compensation will vary. This position may also be eligible for a discretionary annual bonus discretionary stock-based long-term incentives (eligibility may vary based on role) paid time off and a benefits package. Benefits include company-sponsored medical dental vision and life insurance plans*.

For additional benefits information visit:

Eligible employees may participate in benefit plans subject to the terms and conditions of the applicable plans.

Gilead Sciences Inc. is committed to providing equal employment opportunities to all employees and applicants for employment and is dedicated to fostering an inclusive work environment comprised of diverse perspectives backgrounds and experiences. Employment decisions regarding recruitment and selection will be made without discrimination based on race color religion national origin sex age sexual orientation physical or mental disabilitygenetic information or characteristic gender identity and expression veteran status or other non-job related characteristics or other prohibited grounds specified in applicable federal state and local order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973 the Vietnam Era Veterans Readjustment Act of 1974 and Title I of the Americans with Disabilities Act of 1990 applicants who require accommodation in the job application process may contact for assistance.

For more information about equal employment opportunity protections please view theKnow Your Rights poster.

NOTICE: EMPLOYEE POLYGRAPH PROTECTION ACT
YOUR RIGHTS UNDER THE FAMILY AND MEDICAL LEAVE ACT

Gilead Sciences will not discharge or in any other manner discriminate against employees or applicants because they have inquired about discussed or disclosed their own pay or the pay of another employee or applicant. However employees who have access to the compensation information of other employees or applicants as a part of their essential job functions cannot disclose the pay of other employees or applicants to individuals who do not otherwise have access to compensation information unless the disclosure is (a) in response to a formal complaint or charge (b) in furtherance of an investigation proceeding hearing or action including an investigation conducted by the employer (c) consistent with the legal duty to furnish information; or (d) otherwise protected by law.

Our environment respects individual differences and recognizes each employee as an integral member of our company. Our workforce reflects these values and celebrates the individuals who make up our growing team.

Gilead provides a work environment free of harassment and prohibited conduct. We promote and support individual differences and diversity of thoughts and opinion.

Please apply via the Internal Career Opportunities portal in Workday.